Dr. Shui On LEUNG
Founder, Chairman of our Board, Executive Director, Chief Executive Officer
Dr. Shui On LEUNG, the Founder, was appointed as a Director and the chairman of our Board in April 2001 and subsequently appointed as our chief executive officer in January 2003 and subsequently designated as an executive Director in June 2019. Dr. Leung is primarily responsible for formulating overall strategic directions, overseeing scientific and clinical R&D activities and managing overall operations of our Group. Dr. Leung has nearly 30 years of experience in the field of molecular immunology and therapeutic monoclonal antibodies. Dr. Leung has been a member of the first session of Biotech Advisory Panel of the Stock Exchange since April 2018. Dr. Leung obtained his bachelor’s and master’s degrees in biochemistry from the Chinese University of Hong Kong in December 1984 and October 1986, respectively. He earned his Ph.D. in molecular biology from the University of Oxford in Oxford, England in May 1990. From 2001, Dr. Leung had been an adjunct professor of the Chinese University of Hong Kong and Fudan University, China etc. Dr. Leung also held several positions in a U.S. leading antibody-drug conjugate company.